+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of ursodeoxycholic acid udca on mucin secretion of the gallbladder a mechanisms whereby udca prolongs cholesterol crystal nucleation



Effects of ursodeoxycholic acid udca on mucin secretion of the gallbladder a mechanisms whereby udca prolongs cholesterol crystal nucleation



Gastroenterology 100(5 Part 2): A804




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031191543

Download citation: RISBibTeXText


Related references

Effects of lovastatin ls ursodeoxycholic acid udca and ls plus udca on bile lipid composition in patients with cholesterol ch gallstones. Gastroenterology 102(4 Part 2): A319, 1992

Prolonged nucleation time nt and delayed growth of cholesterol crystals in human gallbladder bile by ursodeoxycholic acid udca treatment. Hepatology 7(5): 1139, 1987

Ursodeoxycholic Acid (UDCA) Therapy of Gallstones. is Correction of Biliary Cholesterol Saturation Index According to Percentage UDCA in Bile Necessary for Prediction of Gallstone Dissolution?. Clinical Science 57(3): 26p.3-27p, 1979

Increased concentration of ursodeoxycholic acid in fecal water during UDCA therapy may cause the colon cancer chemoprevention effects of UDCA by enhancing apoptosis. Gastroenterology 112(4 Suppl. ): A610, 1997

Ursodeoxycholic acid (UDCA) in the treatment of cholesterol cholelithiasis of the gallbladder and bile ducts. Polski Tygodnik Lekarski 38(7): 221-224, 1983

Effect of ursodeoxycholic acid (UDCA) on pancreatic enzyme secretion and gallbladder emptying. Pancreas 5(2): 128-135, 1990

Effect of Ursodeoxycholic Acid (UDCA) on Pancreatic Enzyme Secretion and Gallbladder (GB) Emptying. Clinical Science 72(S16): 31p.3-32p, 1987

Influence of ursodeoxycholic acid udca treatment on the formation of cholesterol monohydrate crystals cmc from cholesterol phospholipid vesicles in human gallbladder bile. Gastroenterology 100(5 Part 2): A749, 1991

Symptomatic gallstones are likely to reoccur after dissolution with ursodeoxycholic acid udca but this may be prevented by low dose udca. Gastroenterology 92(5 Part 2): 1787, 1987

Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes. Alimentary Pharmacology and Therapeutics 43(2): 283-293, 2016

A simple rapid and non invasive test of compliance to oral ursodeoxycholic acid udca therapy detection of udca sulfate a specific urinary metabolite. Hepatology 14(4 Part 2): 261A, 1991

Mo1930 Beneficial Effect of Ursodeoxycholic Acid (UDCA) and Its Derivative UDCA-Cpa in Attenuation of Functional Impairment of Esophageal Mucosa in Rat Model of Barrett's Esophagus. Gastroenterology 144(5): S-697-S-698, 2013

A new amino acid derivative of ursodeoxycholate, (N-L-Glutamyl)-UDCA (UDCA-Glu), to selectively release UDCA in the colon. Anticancer Research 29(12): 4971-4979, 2009

Increased liver tissue ursodeoxycholic acid concentration and reduced lithocholate formation in rats orally administered the taurine conjugate of UDCA compared with unconjugated UDCA. Gastroenterology 108(4 Suppl. ): A1156, 1995

Effect of ursodeoxycholic acid (UDCA) treatment on nucleation time (NT). Nihon Shokakibyo Gakkai Zasshi 85(8): 1530-1535, 1988